Arlington Partners LLC

Position in NVS — Novartis AG

CIK 1389848 BIRMINGHAM, AL

Position in NVS

as of Jun 30, 2026 · filed Jul 7, 2026 Compact

Position Value

$247,460

+$6,268 QoQ

Shares Held

1,579

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

1.27%

of 13F equity value

Holder Rank

#1,219

of 1,603 holders

Holding Since

Mar 2021

16 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Arlington Partners LLC holds $1,299,554 across 5 Drug Manufacturers - General names. NVS ranks #4 (19.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NVO	Novo Nordisk A S	6,777	$324,889
2	GSK	GSK plc	5,388	$282,438
3	BMY	Bristol Myers Squibb Co	4,854	$279,687
4	NVS	Novartis AG This page	1,579	$247,460
5	JNJ	Johnson & Johnson	650	$165,080

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$247,460	1,579	0.0%	Shares	Sole	2026-07-07
2026-03-31	$241,192	1,579	-96.0%	Shares	Sole	2026-04-09
2025-09-30	$5,081,894	39,628	+1.9%	Shares	Sole	2025-10-28
2025-06-30	$4,707,894	38,905	-4.8%	Shares	Sole	2025-07-14
2025-03-31	$4,557,525	40,882	+31.2%	Shares	Sole	2025-04-23
2024-12-31	$3,031,401	31,152	-17.1%	Shares	Sole	2025-01-29
2024-09-30	$4,319,691	37,556	+20.6%	Shares	Sole	2024-10-21
2024-06-30	$3,316,441	31,152	+5.1%	Shares	Sole	2024-08-06
2024-03-31	$2,867,947	29,649	0.0%	Shares	Sole	2024-04-16
2023-12-31	$2,993,659	29,649	+2.1%	Shares	Sole	2024-01-24
2023-09-30	$2,956,588	29,026	+9143.9%	Shares	Sole	2023-10-24
2022-06-30	$26,542	314	0.0%	Shares	Sole	2022-07-25
2022-03-31	$27,553	314	0.0%	Shares	Sole	2022-04-14
2021-12-31	$27,465	314	+1063.0%	Shares	Sole	2022-01-18
2021-06-30	$2,463	27	0.0%	Shares	Sole	2021-07-07
2021-03-31	$2,307	27	—	Shares	Sole	2021-04-19
No filing history on record for this holder in this stock.